Quality of Life in Newly Diagnosed Moderate-to-Severe Ulcerative Colitis: Changes in the MOSAIK Cohort Over 1 Year
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background/Aims: Improving quality of life has been gaining importance in ulcerative colitis (UC) management. The aim of this study was to investigate changes in health-related quality of life (HRQL) and related factors in patients with moderate-to-severe UC. Methods: A multicenter, hospital-based, prospective study was performed using a Moderateto- Severe Ulcerative Colitis Cohort in Korea (the MOSAIK). Changes in HRQL, evaluated using the 12-Item Short Form Health Survey (SF-12) and Inflammatory Bowel Disease Questionnaire (IBDQ), were analyzed at the time of diagnosis and 1 year later. Results: In a sample of 276 patients, the mean age was 38.4 years, and the majority of patients were male (59.8%). HRQL tended to increase in both the IBDQ and SF-12 1 year after diagnosis. A higher partial Mayo score was significantly related to poorer HRQL on the IBDQ and SF-12 in a linear mixed model (p<0.01). Inflammatory markers such as C-reactive protein (CRP) or erythrocyte sedimentation rate also showed a negative correlation on HRQL (p<0.05). Patients whose IBDQ score improved by 16 or more (71.2%) in 1 year were younger, tended to be nonsmokers, and had a lower partial Mayo score and CRP than those whose IBDQ score did not. There was no significant association between HRQL and disease extent, treatments at diagnosis, or the highest treatment step during the 1-year period. Conclusions: Optimally controlled disease status improves HRQL in patients with moderate-tosevere UC. The partial Mayo score and inflammatory markers may be potential indicators reflecting the influence of UC on patient`s daily lives.
Abstract
Background/Aims: Improving quality of life has been gaining importance in ulcerative colitis (UC) management. The aim of this study was to investigate changes in health-related quality of life (HRQL) and related factors in patients with moderate-to-severe UC. Methods: A multicenter, hospital-based, prospective study was performed using a Moderateto- Severe Ulcerative Colitis Cohort in Korea (the MOSAIK). Changes in HRQL, evaluated using the 12-Item Short Form Health Survey (SF-12) and Inflammatory Bowel Disease Questionnaire (IBDQ), were analyzed at the time of diagnosis and 1 year later. Results: In a sample of 276 patients, the mean age was 38.4 years, and the majority of patients were male (59.8%). HRQL tended to increase in both the IBDQ and SF-12 1 year after diagnosis. A higher partial Mayo score was significantly related to poorer HRQL on the IBDQ and SF-12 in a linear mixed model (p<0.01). Inflammatory markers such as C-reactive protein (CRP) or erythrocyte sedimentation rate also showed a negative correlation on HRQL (p<0.05). Patients whose IBDQ score improved by 16 or more (71.2%) in 1 year were younger, tended to be nonsmokers, and had a lower partial Mayo score and CRP than those whose IBDQ score did not. There was no significant association between HRQL and disease extent, treatments at diagnosis, or the highest treatment step during the 1-year period. Conclusions: Optimally controlled disease status improves HRQL in patients with moderate-tosevere UC. The partial Mayo score and inflammatory markers may be potential indicators reflecting the influence of UC on patient`s daily lives.
참고문헌 (49)
- Baumgartner RN, "Epidemiology of sarcopenia among the elderly in New Mexico", Am J Epidemiol, 147, pp.755~763 (1998)
- Feuerstein JD, "Ulcerative colitis", Mayo Clin Proc, 94, pp.1357~1373 (2019)
- Trigo-Vicente C, "Systematic review and network meta-analysis of treatment for moderate-to-severe ulcerative colitis", Int J Clin Pharm, 40, pp.1411~1419 (2018)
- Singh S, "Systematic review with network meta-analysis : first-and second-line pharmacotherapy for moderate-severe ulcerative colitis", Aliment Pharmacol Ther, 47, pp.162~175 (2018)
- Kemp K, "Second N-ECCO consensus statements on the European nursing roles in caring for patients with Crohn's disease or ulcerative colitis", J Crohns Colitis, 12, pp.760~776 (2018)
- Sarid O, "Differing relationship of psycho-social variables with active ulcerative colitis or Crohn's disease", Int J Behav Med, 25, pp.341~350 (2018)
- Larsson K, "Stress, coping and support needs of patients with ulcerative colitis or Crohn's disease : a qualitative descriptive study", J Clin Nurs, 26, pp.648~657 (2017)
- Jung Rock Moon, "Unmet Psychosocial Needs of Patients Newly Diagnosed with Ulcerative Colitis: Results from the Nationwide Prospective Cohort Study in Korea", Gut and Liver, 14(4), pp.459~467 (2020), 거트앤리버 소화기연관학회협의회[DOI]
- Daperno M, "Unmet medical needs in the management of ulcerative colitis : results of an Italian Delphi consensus", Gastroenterol Res Pract, 2019, pp.3108025~ (2019)
- Ho EY, "Ulcerative colitis : what is the optimal treatment goal and how do we achieve it?", Curr Treat Options Gastroenterol, 13, pp.130~142 (2015)
- Gajendran M, "A comprehensive review and update on ulcerative colitis", Dis Mon, 65, pp.100851~ (2019)
- Rivett L, "The relationship between quality of life and compliance to a brace protocol in adolescents with idiopathic scoliosis : a comparative study", BMC Musculoskelet Disord, 10, pp.5~ (2009)
- Yarur AJ, "Predictors of aggressive inflammatory bowel disease", Gastroenterol Hepatol(N Y), 7, pp.652~659 (2011)
- Chang Kyun Lee, "A new opportunity for innovative inflammatory bowel disease research: the moderate-to-severe ulcerative colitis in Korea (MOSAIK) cohort study", Intestinal research, 17(1), pp.1~5 (2019), 대한장연구학회[DOI]
- D’Haens G, "A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis", Gastroenterology, 132, pp.763~786 (2007)
- Kim WH, "Quality of life in Korean patients with inflammatory bowel diseases : ulcerative colitis, Crohn's disease and intestinal Behçet's disease", Int J Colorectal Dis, 14, pp.52~57 (1999)
- Feagan BG, "Effects of vedolizumab on health-related quality of life in patients with ulcerative colitis : results from the randomised GEMINI 1 trial", Aliment Pharmacol Ther, 45, pp.264~275 (2017)
- Gregor JC, "An evaluation of utility measurement in Crohn's disease", Inflamm Bowel Dis, 3, pp.265~276 (1997)
- Huoponen S, "Health-related quality of life and costs of switching originator infliximab to biosimilar one in treatment of inflammatory bowel disease", Medicine(Baltimore), 99, pp.e18723~ (2020)
- Ware J Jr, "A 12-Item Short-Form Health Survey : construction of scales and preliminary tests of reliability and validity", Med Care, 34, pp.220~233 (1996)
- Busija L, "Adult measures of general health and health-related quality of life: medical outcomes Study Short Form 36-Item (SF-36) and Short Form 12-Item (SF-12)Health Surveys, Nottingham Health Profile (NHP), Sickness Impact Profile (SIP), Medical Outcomes Study Short Form 6D (SF-6D), Health Utilities Index Mark 3 (HUI3), Quality of Well-Being Scale (QWB), and Assessment of Quality of Life (AQoL)", Arthritis Care Res (Hoboken), 11, pp.S383~S412 (2011)
- Gandek B, "Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries : results from the IQOLA Project. International Quality of Life Assessment", J Clin Epidemiol, 51, pp.1171~1178 (1998)
- Stepaniuk P, "Characterization of inflammatory bowel disease in elderly hospitalized patients in a large central Canadian Health region", Can J Gastroenterol Hepatol, 29, pp.274~278 (2015)
- Burisch J, "Natural disease course of ulcerative colitis during the first five years of follow-up in a European population-based inception cohort : an Epi-IBD study", J Crohns Colitis, 13, pp.198~208 (2019)
- Müller O, "Patient's early satisfaction with care : a predictor of health-related quality of life change among outpatients with substance dependence", Health Qual Life Outcomes, 18, pp.6~ (2020)
- Burisch J, "Health-related quality of life improves during one year of medical and surgical treatment in a European population-based inception cohort of patients with inflammatory bowel disease : an ECCOEpiCom study", J Crohns Colitis, 8, pp.1030~1042 (2014)
- Cao Q, "The prevalence and risk factors of psychological disorders, malnutrition and quality of life in IBD patients", Scand J Gastroenterol, 54, pp.1458~1466 (2019)
- Fourie S, "Living with inflammatory bowel disease : a review of qualitative research studies", Int J Nurs Stud, 87, pp.149~156 (2018)
- Knowles SR, "Quality of life in inflammatory bowel disease : a systematic review and meta-analyses. Part I", Inflamm Bowel Dis, 24, pp.742~751 (2018)
- Christiansen LK, "Health-related quality of life in inflammatory bowel disease in a Danish population-based inception cohort", United European Gastroenterol J, 7, pp.942~954 (2019)
- Huppertz-Hauss G, "Health-related quality of life in patients with inflammatory bowel disease 20 years after diagnosis : results from the IBSEN study", Inflamm Bowel Dis, 22, pp.1679~1687 (2016)
- Sandborn WJ, "Subcutaneous golimumab induces clinical response and remission in patients with moderate-to-severe ulcerative colitis", Gastroenterology, 146, pp.85~95 (2014)
- Loftus EV Jr, "Long-term efficacy of vedolizumab for ulcerative colitis", J Crohns Colitis, 11, pp.400~411 (2017)
- Sparrow MP, "Adalimumab in ulcerative colitis : efficacy, safety and optimization in the era of treat-to target", Expert Opin Biol Ther, 17, pp.613~621 (2017)
- Fernández-Clotet A, "Tofacitinib for the treatment of ulcerative colitis", Expert Rev Clin Immunol, 14, pp.881~892 (2018)
- van der Have M, "Back", joint pain, illness perceptions and coping are important predictors of quality of life and work productivity in patients with inflammatory bowel disease : a 12-month longitudinal study, 2015, pp.9, 276~283
- Leong RW, "Prospective validation study of the International Classification of Functioning, Disability and Health score in Crohn's disease and ulcerative colitis", J Crohns Colitis, 8, pp.1237~1245 (2014)
- Marinelli C, "Factors associated with disability in patients with ulcerative colitis : a crosssectional study", J Dig Dis, 21, pp.81~87 (2020)
- Magalhães J, "Disability in inflammatory bowel disease : translation to Portuguese and validation of the"Inflammatory Bowel Disease-Disability Score"", GE Port J Gastroenterol, 22, pp.4~14 (2015)
- GraffLA, "A population-based study of fatigue and sleep difficulties in inflammatory bowel disease", Inflamm Bowel Dis, 17, pp.1882~1889 (2011)
- 유수현, "Fatigue Severity and Factors Associated with High Fatigue Levels in Korean Patients with Inflammatory Bowel Disease", Gut and Liver, 8(2), pp.148~153 (2014), 거트앤리버 소화기연관학회협의회
- Sadeghi N, "The effect of curcumin supplementation on clinical outcomes and inflammatory markers in patients with ulcerative colitis", Phytother Res, 34, pp.1123~1133 (2020)
- Abautret-Daly Á, "Association between psychological measures with inflammatory anddisease-related markers of inflammatory bowel disease", Int J Psychiatry Clin Pract, 21, pp.221~230 (2017)
- Slonim-Nevo V, "Effect of psychosocial stressors on patients with Crohn's disease : threatening life experiences and family relations", Eur J Gastroenterol Hepatol, 28, pp.1073~1081 (2016)
- Velonias G, "Older age-and health-related quality of life in inflammatory bowel diseases", Inflamm Bowel Dis, 23, pp.283~288 (2017)
- Kamp KJ, "Health-related quality of life among patients with inflammatory bowel disease : a case control study", Gastroenterol Nurs, 44, pp.21~30 (2021)
- Owczarek D, "Diet and nutritional factors in inflammatory bowel diseases", World J Gastroenterol, 22, pp.895~905 (2016)
- Severs M, "Smoking is associated with higher disease-related costs and lower health-related quality of life in inflammatory bowel disease", J Crohns Colitis, 11, pp.342~352 (2017)
- Bruna-Barranco I, "Young age and tobacco use are predictors of lower medication adherence in inflammatory bowel disease", Eur J Gastroenterol Hepatol, 31, pp.948~953 (2019)